Evidence map›Paper›PMID 28636641›Full record

ArticlePloS one2017

Development of a range of fluorescent reagentless biosensors for ATP, based on malonyl-coenzyme A synthetase.

Renée Vancraenenbroeck, Simone Kunzelmann, Martin R Webb

Abstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Renée VancraenenbroeckThe Francis Crick Institute, London, United Kingdom.
Simone KunzelmannStructural Biology Science Technology Platform, The Francis Crick Institute, London, United Kingdom.
Martin R WebbThe Francis Crick Institute, London, United Kingdom.

Funding

Wellcome Trust FC001211
6 · The paper itself

Abstract

The range of ATP concentrations that can be measured with a fluorescent reagentless biosensor for ATP has been increased by modulating its affinity for this analyte. The ATP biosensor is an adduct of two tetramethylrhodamines with MatB from Rhodopseudomonas palustris. Mutations were introduced into the binding site to modify ATP binding affinity, while aiming to maintain the concomitant fluorescence signal. Using this signal, the effect of mutations in different parts of the binding site was measured. This mutational analysis revealed three variants in particular, each with a single mutation in the phosphate-binding loop, which had potentially beneficial changes in ATP binding properties but preserving a fluorescence change of ~3-fold on ATP binding. Two variants (T167A and T303A) weakened the binding, changing the dissociation constant from the parent's 6 μM to 123 μM and 42 μM, respectively. Kinetic measurements showed that the effect of these mutations on affinity was by an increase in dissociation rate constants. These variants widen the range of ATP concentration that can be measured readily by this biosensor to >100 μM. In contrast, a third variant, S170A, decreased the dissociation constant of ATP to 3.8 μM and has a fluorescence change of 4.2 on binding ATP. This variant has increased selectivity for ATP over ADP of >200-fold. This had advantages over the parent by increasing sensitivity as well as increasing selectivity during ATP measurements in which ADP is present.

Indexed as

Biosensing TechniquesAdenosine DiphosphateAdenosine TriphosphateBacterial ProteinsBinding SitesCoenzyme A LigasesFluorescent DyesKineticsMolecular Dynamics SimulationMutagenesis, Site-DirectedProtein BindingProtein Structure, TertiaryPyruvate KinaseRhodaminesRhodopseudomonasAdenosine DiphosphateAdenosine TriphosphateBacterial ProteinsCoenzyme A LigasesFluorescent Dyesmalonyl-CoA synthetasePyruvate KinaseRhodaminestetramethylrhodamine

Identifiers

PMID28636641
PMCPMC5479551

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.